Abstract:Yijuan Feng, 1, &ast Yan Wang, 1, &ast Li Li, 1, &ast Yan Yang, 1 Xiaoqiu Tan, 1– 3 Tangting Chen 1, 2 1 Key Laboratory of Medical Electrophysiology of the Ministry of Education, Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, People's Republic of China; 2 Department of Cardiology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China; 3 Department of Physiology, School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Tangting Chen; Xiaoqiu Tan, Key Laboratory of Medical Electrophysiology of the Ministry of Education, Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, People's Republic of China, Email ; Recanalization therapy can significantly improve the prognosis of patients with acute myocardial infarction (AMI). However, infarction or reperfusion-induced cardiomyocyte death, immune cell infiltration, fibroblast proliferation, and scarring formation lead to cardiac remodeling and gradually progress to heart failure or arrhythmia, resulting in a high mortality rate. Due to the inability of cardiomyocytes to regenerate, the healing of infarcted myocardium mainly relies on the formation of scars. Cardiac fibroblasts, as the main effector cells involved in repair and scar formation, play a crucial role in maintaining the structural integrity of the heart after MI. Recent studies have revealed that exosome-mediated intercellular communication plays a huge role in myocardial repair and signaling transduction after myocardial infarction (MI). Exosomes can regulate the biological behavior of fibroblasts by activating or inhibiting the intracellular signaling pathways through their contents, which are derived from cardiomyocytes, immune cells, endothelial cells, mesenchymal cells, and others. Understanding the interactions between fibroblasts and other cell types during cardiac remodeling will be the key to breakthrough therapies. This review examines the role of exosomes from different sources in the repair process after MI injury, especially the impacts on fibroblasts during myocardial remodeling, and explores the use of exosomes in the treatment of myocardial remodeling after MI. Keywords: exosomes, myocardial infarction, myocardial fibrosis, cardiac fibroblasts Myocardial infarction (MI) is the most serious manifestation of coronary artery disease and a major cause of related deaths. 1 The main clinical treatment for MI aims to unblock the coronary artery, restore blood flow, and minimize post-infarction myocardial remodeling. 2 Adult myocardial cells cannot regenerate after necrosis, so the maintenance of normal cardiac structure after MI mainly relies on the proliferation of fibroblasts. 3 However, cardiac fibrosis and remodeling caused by continuous fibroblast activation 4 still requires the further search for new therapeutic strategies. Studies on extracellular vesicles have exponentially increased in the past decade, from basic researches to clinical translational applications. Due to the endogenous, biocompatible and multifunctional properties, the extracellular vesicles may become a novel treatment for various cardiac diseases in the future. 5,6 Exosomes being paracrine is a key pathway for intercellular information exchange, transporting critical proteins 7 and genetic material (such as miRNA, 8 mRNA, 9 and DNA 10 ), mediating the transfer of various biomolecules between cells, which is an important component of various physiological and pathological processes. 11 Recent studies have shown that various types of cells, including myocardial cells, 12,13 endothelial cells (ECs), 14 immune cells, 15 and stem cells, 16 can secrete extracellular vesicles to participate in the process of myocardial remodeling. Certain extracellular vesicles exhibit significant advantages in myocardial remodeling after heart attack, while others aggravate the progression of myocardial remodeling. Although there are literature reviews on the effects of exosomes on cardiovascular diseases, as well as how the contents of exosomes (microRNA (miRNA), non-coding RNAs (ncRNA), long non-coding RNAs (lncRNA) et al) affect cardiac fibrosis or myocardial remodeling processes after MI, 17–19 there is currently no literature that specifically explains how exosomes and the -Abstract Truncated-

Intercellular Mitochondrial Component Transfer Triggers Ischemic Cardiac Fibrosis.

Cardiomyocytes Deficiency of SENP1 Promotes Myocardial Fibrosis Via Paracrine Action

Bone marrow-fibroblast progenitor cell-derived small extracellular vesicles promote cardiac fibrosis via miR-21-5p and integrin subunit αV signalling

Bnip3 promotes the release of mitochondria-derived extracellular vesicles in cardiac fibroblasts to exacerbate inflammation response after myocardial infarction

The Mechanism of SIRT3 Regulating SRV2-Mediated Mitochondrial Fission of Fibroblasts to Inhibit Myocardial Fibrosis after Acute Myocardial Infarction

Exosomal miR-15a-5p from cardiomyocytes promotes myocardial fibrosis

Exosomes Derived from Cardiomyocytes Promote Cardiac Fibrosis Via Myocyte-Fibroblast Cross-Talk.

Extracellular vesicles mediate biological information delivery: A double-edged sword in cardiac remodeling after myocardial infarction

Cardiomyocyte-derived small extracellular vesicle: a new mechanism driving diabetic cardiac fibrosis and cardiomyopathy

Cardiac fibroblasts-mtExosomes-macrophages axis aggravates ventricular remodeling after acute myocardial infarction

Human cardiomyocyte derived extracellular vesicles regulate cardiac fibroblast activation through miR-24

Increased perivascular fibrosis and pro-fibrotic cellular transition in intramyocardial blood vessels in patients with myocardial infarction

MicroRNAs Involved in the Regulation of Postischemic Cardiac Fibrosis

Extracellular vesicle‐packaged mitochondrial disturbing miRNA exacerbates cardiac injury during acute myocardial infarction

Extracellular Matrix Protein-1 as a Mediator of Inflammation-Induced Fibrosis After Myocardial Infarction

Abstract 13754: Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Alleviate Fibrosis by Reducing Energy Production of Cardiac Fibroblast via Glutamate Metabolism Regulation

Seamless Genetic Recording of Transiently Activated Mesenchymal Gene Expression in Endothelial Cells During Cardiac Fibrosis

miR-24-3p secreted as extracellular vesicle cargo by cardiomyocytes inhibits fibrosis in human cardiac microtissues

Exosomes Induce Crosstalk Between Multiple Types of Cells and Cardiac Fibroblasts: Therapeutic Potential for Remodeling After Myocardial Infarction

Small Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Enhanced Proangiogenic Potential of Cardiac Fibroblasts via Angiopoietin-Like 4

Myocardial fibrosis in right heart dysfunction